Your browser doesn't support javascript.
loading
Therapeutic potential of ghrelin and des-acyl ghrelin against chemotherapy-induced cardiotoxicity.
Nonaka, Miki; Kurebayashi, Nagomi; Murayama, Takashi; Sugihara, Masami; Terawaki, Kiyoshi; Shiraishi, Seiji; Miyano, Kanako; Hosoda, Hiroshi; Kishida, Shosei; Kangawa, Kenji; Sakurai, Takashi; Uezono, Yasuhito.
Afiliación
  • Nonaka M; Division of Cancer Pathophysiology, National Cancer Center Research Institute, Tokyo 104-0045, Japan.
  • Kurebayashi N; Department of Cellular and Molecular Pharmacology, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan.
  • Murayama T; Department of Cellular and Molecular Pharmacology, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan.
  • Sugihara M; Department of Clinical Laboratory Medicine, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan.
  • Terawaki K; Division of Cancer Pathophysiology, National Cancer Center Research Institute, Tokyo 104-0045, Japan.
  • Shiraishi S; Tsumura Kampo Research Laboratories, Kampo Research & Development Division, Tsumura & Co., Ibaraki 300-1192, Japan.
  • Miyano K; Division of Cancer Pathophysiology, National Cancer Center Research Institute, Tokyo 104-0045, Japan.
  • Hosoda H; Division of Cancer Pathophysiology, National Cancer Center Research Institute, Tokyo 104-0045, Japan.
  • Kishida S; Department of Regenerative Medicine and Tissue Engineering, National Cerebral and Cardiovascular Center Research Institute, Suita 565-8565, Japan.
  • Kangawa K; Department of Biochemistry and Genetics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima 890-8544, Japan.
  • Sakurai T; National Cerebral and Cardiovascular Center Research Institute, Suita 565-8565, Japan.
  • Uezono Y; Department of Cellular and Molecular Pharmacology, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan.
Endocr J ; 64(Suppl.): S35-S39, 2017.
Article en En | MEDLINE | ID: mdl-28652542

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Doxorrubicina / Sustancias Protectoras / Ghrelina / Cardiotoxicidad / Corazón / Antineoplásicos Límite: Animals Idioma: En Revista: Endocr J Asunto de la revista: ENDOCRINOLOGIA Año: 2017 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Doxorrubicina / Sustancias Protectoras / Ghrelina / Cardiotoxicidad / Corazón / Antineoplásicos Límite: Animals Idioma: En Revista: Endocr J Asunto de la revista: ENDOCRINOLOGIA Año: 2017 Tipo del documento: Article País de afiliación: Japón